Thomas W. Beetham - 27 Sep 2024 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Chief Operating Officer
Signature
/s/Thomas Beetham
Issuer symbol
VRDN
Transactions as of
27 Sep 2024
Net transactions value
+$117,050
Form type
4
Filing time
30 Sep 2024, 19:12:50 UTC
Previous filing
01 Nov 2023
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRDN Common Stock Purchase $117,050 +5,000 +500% $23.41 6,000 27 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on September 19, 2024 in transactions that were exempt under Rule 16b-3(c).

Remarks:

Exhibit 24 - Power of Attorney